Barnes Dennig Private Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.85K Hold
15
﹤0.01% 280
2026
Q1
$2.53K Hold
15
﹤0.01% 280
2025
Q4
$2.53K Hold
15
﹤0.01% 285
2025
Q3
$2.17K Hold
15
﹤0.01% 276
2025
Q2
$1.9K Hold
15
﹤0.01% 274
2025
Q1
$1.92K Buy
+15
New +$2.03K ﹤0.01% 208

Other funds holding IBB

Barnes Dennig Private Wealth Management's IBB Position: Q2 2026 in Review

Barnes Dennig Private Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 15 shares worth $2.85K. The position accounts for ﹤0.01% of the portfolio, ranked #280.

Barnes Dennig Private Wealth Management first reported a position in IBB in Q1 2025 and has held it in 6 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Barnes Dennig Private Wealth Management held 15 shares of iShares Biotechnology ETF worth $2.85K as of Q2 2026.
  • Barnes Dennig Private Wealth Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Barnes Dennig Private Wealth Management's portfolio in Q2 2026, its #280 holding.
  • Barnes Dennig Private Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2025 and has held it in 6 quarters since.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Barnes Dennig Private Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.